Company Filing History:
Years Active: 2003
Title: Geraldine O'Neill: Innovator in Cellular Morphology Research
Introduction
Geraldine O'Neill is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of cellular biology, particularly in understanding the mechanisms that affect cellular morphology, locomotion, and death. His innovative work has led to the development of valuable research tools and therapeutic agents.
Latest Patents
Geraldine O'Neill holds a patent for "Methods for identifying agents which affect cellular morphology, locomotion and death." This patent includes an isolated nucleic acid molecule that encodes a mammalian signal mediator protein, HEF-1. This protein plays a crucial role in regulating cellular morphological alterations. The invention also encompasses the novel signal mediator protein and antibodies, which are useful in identifying, detecting, and regulating complex signaling events that lead to significant cellular changes.
Career Highlights
Geraldine O'Neill is affiliated with the Fox Chase Cancer Center, where he conducts research aimed at advancing our understanding of cellular processes. His work has implications for both basic research and potential therapeutic applications.
Collaborations
Throughout his career, Geraldine has collaborated with esteemed colleagues, including Erica A Golemis and Sarah Fashena. These collaborations have further enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Geraldine O'Neill's innovative contributions to cellular biology and his patent on HEF-1 highlight his role as a significant inventor in the scientific community. His work continues to influence research and therapeutic strategies in understanding cellular behavior.